GZF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.6354474158552E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.01247956871975E-13 |
Normal-vs-Stage2 |
6.59269971947651E-10 |
Normal-vs-Stage3 |
6.36601882320065E-13 |
Normal-vs-Stage4 |
5.07810460348423E-11 |
Stage1-vs-Stage2 |
3.419400E-01 |
Stage1-vs-Stage3 |
5.866800E-01 |
Stage1-vs-Stage4 |
5.352600E-01 |
Stage2-vs-Stage3 |
2.309200E-01 |
Stage2-vs-Stage4 |
7.448800E-01 |
Stage3-vs-Stage4 |
3.570200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.36668454331357E-12 |
Normal-vs-AfricanAmerican |
1.08801856413265E-12 |
Normal-vs-Asian |
1.60208999999689E-05 |
Caucasian-vs-AfricanAmerican |
4.711600E-01 |
Caucasian-vs-Asian |
4.427200E-01 |
AfricanAmerican-vs-Asian |
5.795200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.1200818878242E-12 |
Normal-vs-Female |
6.14852613267658E-12 |
Male-vs-Female |
1.605840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.38125100035813E-12 |
Normal-vs-Age(41-60Yrs) |
3.31989991053661E-12 |
Normal-vs-Age(61-80Yrs) |
2.99416047511158E-12 |
Normal-vs-Age(81-100Yrs) |
5.0951999952531E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.769600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.578600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.565800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.673000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.892400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.461800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.86209999997189E-06 |
Normal-vs-Grade 2 |
6.38145092324294E-12 |
Normal-vs-Grade 3 |
1.75026659832156E-12 |
Normal-vs-Grade 4 |
2.78550515986353E-11 |
Grade 1-vs-Grade 2 |
9.287000E-01 |
Grade 1-vs-Grade 3 |
4.105000E-01 |
Grade 1-vs-Grade 4 |
8.704000E-01 |
Grade 2-vs-Grade 3 |
4.936300E-02 |
Grade 2-vs-Grade 4 |
8.442600E-01 |
Grade 3-vs-Grade 4 |
2.783600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.85722573273506E-13 |
Normal-vs-ccB subtype |
1.25119914429206E-11 |
ccA subtype-vs-ccB subtype |
1.881190E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.36273239756702E-12 |
Normal-vs-N1 |
3.81590000042564E-07 |
N0-vs-N1 |
9.747000E-01 |
|
|